UK trial will evaluate safety of mixing different COVID-19 vaccines
Com-Cov study will be the first in the world to evaluate using different vaccines in a two-dose regimen
Read More
Tag: Mixed-vaccine regimen
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
